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complexes derived from therapeutic microspheres
by infrared ion spectroscopy†
Kas J. Houthuijs, a Jonathan Martens, *a Alexandra G. Arranja,bcd
Giel Berden, a J. Frank W. Nijsencd and Jos Oomens *ae
Microspheres containing radioactive 166holmium-acetylacetonate are employed in emerging radionuclide
therapies for the treatment of malignancies. At the molecular level, details on the coordination geometries
of the Ho complexes are however elusive. Infrared ion spectroscopy (IRIS) was used to characterize several
165Ho-acetylacetonate complexes derived from non-radioactive microspheres. The coordination geometry
of four distinct ionic complexes were fully assigned by comparison of their measured IR spectra with
spectra calculated at the density functional theory (DFT) level. The coordination of each acetylacetonate
ligand is dependent on the presence of other ligands, revealing an asymmetric chelation motif in some
of the complexes. A fifth, previously unknown constituent of the microspheres was identified as a
coordination complex containing an acetic acid ligand. These results pave the way for IRIS-based
identification of microsphere constituents upon neutron activation of the metal center.
Introduction
Over the past two decades, the lanthanide holmium has seen a
steady increase in the number of radionuclide therapy applica-
tions. This interest is driven by the possibility to convert
holmium-165 into radioactive holmium-166 upon neutron activa-
tion (165Ho + n - 166Ho).1,2 With a half-life of 26.8 hours,
holmium-166 decays into erbium-166 through the emission of
beta-minus particles (b) and low-energy gamma photons.3,4 The
b particles can be used to kill tumor cells, while the emitted
gamma photons enable visualization and quantification of the
isotope distribution in vivo by single-photon emission computed
tomography (SPECT).5–8 In addition, holmium has a high X-ray
attenuation coefficient and paramagnetic properties, which allow
its visualization by computed tomography (CT) and high-
resolution magnetic resonance imaging (MRI), respectively.5,8
Holmium microspheres with a defined size distribution
(20–50 mm) are an ideal medical device for selective internal
radiation therapy (SIRT) of liver malignancies.5–7 Microspheres
based on holmium acetylacetonate complexes are particularly
attractive from a clinical perspective because of their high
holmium content of B47 wt%, giving them the possibility to
achieve a high specific activity (MBq mg1) and hence
improved imaging and quantification performance in MRI and
CT.8–10 Moreover, they pave the way towards other clinical
applications such as radiation segmentectomy and interstitial
micro brachytherapy.9,11–13 The holmium-acetylacetonate micro-
spheres are formed using as precursor holmium-acetylacetonate
crystals, Ho(acac–H)3H2O. The crystalline structure of this pre-
cursor has been previously elucidated by X-ray crystallography.14
The chemical composition of the microspheres (Ho2(acac–H)32H2O)
and their amorphous structure has also been recently described.9
It has been hypothesized that in these microspheres, deprotonated
acac and holmium form a network, with additional water mole-
cules coordinating to the holmium.10 A detailed investigation of
the coordination structures in the microspheres has not been
reported thus far.
Here, coordination complexes of Ho and [acac–H] isolated
from microspheres are structurally characterized in the gas
phase of a mass spectrometer. Although different from the
condensed phase of the microspheres, the gas phase can
provide fundamental insight in structural properties of the
complexes. This is in contrast to X-ray crystallography, which
cannot be readily applied to the amorphous microspheres.
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Previous research on gas-phase holmium-ligand complexes
includes a mass-spectrometric (MS) study on the chelation with
fluorinated acac15 and glucose.16 The former was combined
with solid-state infrared transmission measurements that
qualitatively described the binding of the ligands. Recent work
has employed MS in combination with density functional
theory (DFT) to investigate the mechanisms of using gas-
phase Ho(I) as a catalyst for carbon bond activation and the
formation of dibenzothiophene.17–19 However, as these studies
are solely based on MS, precise geometries were not experi-
mentally verified. Here we employ infrared ion spectroscopy
(IRIS), a combination of MS and IR spectroscopy, to determine
the coordination motifs of the complexes by mass-selective
probing of their vibrational fingerprints. This approach has
previously been used to probe metal–ligand interactions
to investigate, for instance, the factors influencing ligand
denticity.20,21 Systems studied involve a wide variety metal
centers including transition metals,22 lanthanides23 and other
f-block metals, such as uranyl complexes, where the OQUQO




Microspheres were prepared by an emulsification and solvent
evaporation method as previously reported.9 Briefly, 10 g of
holmium acetylacetonate crystals2 were dissolved in 186 g of
chloroform and the solution was added to 1 liter of an aqueous
solution of poly-vinyl alcohol (2% w/w). Overhead four blades
propeller stirrers (IKA Eurostar power digi-visc) were used to
vigorously stir the mixture in two liters baffled beakers to
obtain an oil-in-water (o/w) emulsion which was stirred at a
constant speed of 300 rpm and temperature of 25 1C. A constant
flow of nitrogen (12 L min1) was applied for 72 h. After
evaporation of the organic solvent, the holmium acetylacetonate
microspheres were formed and sieved to the desired size
(20–50 mm) using an electronic sieve vibrator (TOPAS EMS
755). The sieved microspheres were dried at room temperature
for 5 hours under ambient pressure followed by vacuum drying
at room temperature for 72 hours. For infrared ion spectro-
scopy analysis, dried powders of the holmium acetylacetonate
microspheres were dissolved in methanol.
Infrared ion spectroscopy
Infrared spectra of the positively charged holmium complexes
were measured in a quadrupole ion trap (QIT) mass spectro-
meter (Bruker, AmaZon Speed ETD, Bremen, Germany),28 which
was coupled to the beamline of the infrared free-electron laser
FELIX.29 An approximately 10 mM solution of the dried powder
of the holmium acetylacetonate microspheres in methanol
was injected and ionized using electrospray ionization (ESI) to
generate positively charged holmium complexes (see Fig. S1
and S2, ESI†). After isolation of the precursor ion of interest,
the ions were irradiated with two 6 ms long macropulses from
FELIX at a repetition rate of 10 Hz, each pulse having an energy
of 20–100 mJ and a bandwidth of about 0.5% of the center
frequency. Wavelength dependent absorption of infrared radia-
tion increases the internal energy of the precursor ion, until the
dissociation threshold is reached and the precursor ion dissoci-
ates (see Fig. S3, ESI†). The wavelength dependent fragmentation





I(all ions)).30 This yield is
linearly corrected for wavelength dependent variations in laser power
and the wavelength is calibrated using a grating spectrometer.
Computational methods
Density functional theory (DFT) calculations were carried out
in Gaussian16,31 using the B3LYP density functional. The
Stuttgart–Dresden small core relativistic effective core-potential
(ECP28MWB) and its associated basis set was used for the
holmium atom32,33 and the 6-31++G(d,p) basis set for the first
and second row atoms. After geometry optimization of the
complexes, without symmetry constraints, a harmonic frequency
calculation was performed. To correct for anharmonic effects,
frequencies were scaled by a uniform factor of 0.975.34 To aid
comparison to experimental spectra, a Gaussian line broadening
of 20 cm1 full width at half maximum was applied to the
calculated stick spectrum. Computed IR fundamental frequen-
cies are given in Tables S1 and S2 (ESI†). Relative energies were
based on the sum of the electronic and thermal free energies of
the B3LYP frequency calculations.
Results and discussion
Infrared spectral assignment of the holmium-ligand complexes
Holmium-ligand complexes are generated by ESI from a solution
of holmium-acetylacetonate containing microspheres dissolved
in methanol. This mainly produced singly charged ions corres-
ponding to a Ho(III) center chelated by two [acac–H] ligands,
resulting in an overall 1+ ion at m/z 363. Three other ions in the
mass spectrum (shown in Fig. S1, ESI†) at m/z values of 381, 395,
and 463 were tentatively assigned as [Ho(acac–H)2L]
+ species,
where L is either water, methanol, or acac, respectively. Multi-
nuclear holmium complexes were not observed, which likely
relates to the acetylacetonate geometry that favours bidentate
binding to a single metal centre (see Scheme 1).
Mass-to-charge ratios provide the stoichiometry of the
observed MS features, but do not reveal the precise chelation
geometry, e.g. which ligands are deprotonated and which of
their atoms act as donors to the central Ho ion. For instance, in
the [Ho(acac)2L  2H]+ systems, both acac ligands may be
deprotonated, but depending on the acidity of L relative to that
of acac, alternative deprotonation isomers are conceivable.
Apart from acidity, the nucleophilicity of the ligands towards
Ho3+ and steric effects likely influence the overall coordination
structure. The acac ligand presents a variety of possible
chelating motifs, both mono- and bidentate, and both as neutral
(acac) or as anion ([acac–H]); diketo and cis-enol binding are
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diketo tautomeric form is energetically more favourable, the
enol tautomer is more abundant in both methanol solution and
in the gas phase,36,37 having a free-energy advantage of approxi-
mately 10 kJ mol1 at 298 K. It may therefore be a reasonable
candidate to be observed upon gradual solvent evaporation in
the ESI process. To derive the chelation structure of the com-
plexes, IRIS spectra were compared with quantum-chemically
computed IR spectra of candidate structures.
Fig. 1 presents the experimental IRIS spectrum of the iso-
lated m/z 381 ion (black trace in all panels). To establish the
deprotonation state and the tautomeric form of the ligands in
[Ho(acac)2(H2O)–2H]
+, the IR spectrum is contrasted against
computed spectra of possible chelation geometries represented
by the coloured traces. Fig. 1a presents the best match, which
suggests that the complex involves an intact water ligand and
two [acac–H] ligands. The absence of the symmetric CO/CO
stretch of diketo acac at 1720 cm1 (Fig. 1b) and the absence of
the hydrogen-bonded OH bend of enol acac at 1580 cm1 (Fig. 1c)
indicate that the coordination complex does not contain a neutral
acac ligand. This is in line with the computed relative free
energies of the structures, given in each panel, and with what is
expected on the basis of the higher acidity of acac relative to water.
Although previous studies have shown that IR spectra
of transition metal coordination complexes can be sensitive
to the spin state of metal center,38,39 this is not the case for
lanthanides. f-Orbitals barely engage in ligand binding, so that
their occupation barely affects chelation and hence IR spectra;
f-orbitals in lanthanides show negligible crystal field splitting
(approximately 1 kJ mol1)40 and here we expect that the
Ho3+ center is in its atomic ground electronic state, which
has quintet spin multiplicity ([Xe]4f10, 5I8). This is indeed
confirmed by computed relative free energies for different spin
states (see Fig. S4, ESI†) and in line with previous DFT inves-
tigations on Ho(III).41 Computed IR spectra in Fig. 1 correspond
to complexes with quintet spin multiplicity.
The remaining coordination complexes were structurally
characterized using an analogous approach. Diagnostic vibra-
tional bands were used to assign the coordination motif of the
ions at m/z 363 [Ho(acac)2–2H]
+, m/z 395 [Ho(acac)2(MeOH)–2H]
+
and m/z 463 [Ho(acac)3–2H]
+, as presented in Fig. 2a, c and d,
respectively. The experimental IR spectra (black) are overlaid onto
the best matching calculated spectrum (blue) for each of the
complexes. In all cases, the lowest-energy structure provides the
best match with experiment. Computed spectra of alternative
candidate structures, including alternative spin multiplicities,
are shown in Fig. S5–S7 (ESI†). These computations follow the
same trend as that for [Ho(acac)2(H2O)–2H]
+.
Effect of third ligand on geometry and IR spectra
Closer inspection shows that the geometries are determined by
maximized interaction of the ligand donor atoms with the metal
centre and ligand–ligand repulsion. This leads to the following





and octahedral for the [Ho(acac–H)2(acac)]
+ ion. These coordina-
tion geometries are slightly distorted due to the limited angle
that bidentate [acac–H] can accommodate and the repulsion
between the third ligand and the [acac–H] ligands (Fig. 2b–d). The
[acac–H] ligands in all complexes adopt a planar OCC(H)CO
structure as a consequence of electron delocalization in the con-
jugated p-orbitals that is typical for deprotonated 1,3-diketones
(see Scheme 1). The neutral acac ligand, on the other hand, has
an sp3-hybridized central carbon atom, which results in the
CH2 sticking out-of-plane (Fig. 2d).
The DFT computations not only allow for the structural
identification of the coordination complexes, but also give insight
into the binding properties of the ligands and how these are
affected by the other ligands. The [Ho(acac–H)2]
+ coordination
complex is taken as the unperturbed system, with its experimental
and computed IR spectrum shown in Fig. 2a. The vibrational
bands are classified as one of five types of modes: delocalized
modes (645 cm1, 930 cm1, 1270 cm1), CH out-of-plane and
in-plane bending modes (810 cm1, 1340 cm1, 1525 cm1),
Scheme 1 Possible tautomers and their nomenclature of acetylacetone
and its conjugated base acetylacetonate.
Fig. 1 Comparison of the calculated spectra (coloured) of three candi-
date structures to the experimental spectrum of the m/z 381 ion (black).
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methyl rocking (1020 cm1), methyl wagging (1340 cm1,
1440 cm1) and CO stretching modes (1525 cm1). These
modes are clearly observed in the experimental IR spectrum,
despite some broadening due to a relatively high dissociation
threshold for this complex. Binding of a third (neutral) ligand
to the [Ho(acac–H)2]
+ ion reduces this threshold and introduces
additional bands as indicated in red in Fig. 2b–d. Binding of
water introduces an H–O–H bending mode at 1580 cm1.
Binding of methanol introduces three significant bands: C–O
stretching at 965 cm1, methyl rocking at 1065 cm1 and COH
bending at 1315 cm1. Binding of a neutral acac ligand
introduces four new bands: CH2 bending at 1150 cm
1,
a delocalized mode at 1210 cm1, CH in plane bending at
1320 cm1 and a symmetric CO stretch at 1735 cm1.
The modes associated with the [acac–H] ligands below
1300 cm1 remain largely unaffected by coordination of addi-
tional ligands. Some of the modes above 1300 cm1, however,
shift significantly in frequency upon additional ligand binding.
The carbonyl stretch of [acac–H] blueshifts by about 30 cm1
upon binding of an additional neutral acac, as is seen in Fig. 3
and 2a, d. The additional ligand reduces the electron density
donation of the other, anionic ligands to the metal center,
increasing the electron density in their CO bonds, blue-shifting
the CO stretch frequencies. This is also reflected in the
increased HoO and reduced CO bond lengths upon coordina-
tion of an additional ligand (see Fig. 3). The value of the shifts
for the three neutral ligands qualitatively follows the order of
their proton affinity, with PA(H2O) o PA(MeOH) o PA(acac),
reflecting the ability of these ligands to donate electron density
to the metal ion.
The geometry of the [acac–H] ligands is also affected by the
binding of the other ligands. Where the ligands in [Ho(acac H)2]+
coordinate symmetrically, with all four C–O and all four Ho–O
bond lengths being equal, this is no longer the case upon
coordination of an additional ligand, see Table 1. In both
[Ho(acac–H)2(H2O)]
+ and [Ho(acac–H)2(MeOH)]
+, one of the
CO bonds in [acac–H] is 0.007 Å shorter than the other.
Together with a small difference in the backbone CC bond
lengths (0.006 Å), this suggests that the [acac–H] ligands
surrender their symmetric bidentate binding and adopt a
slightly ‘‘enol-fashion’’ binding. Although these bond length
differences are small, they are reproduced in all [acac–H]
ligands in the two coordination complexes. This shift towards
enol character parallels the ongoing discussion concerning the
symmetry of the hydrogen sharing in the cis enol tautomer of
acac (see Scheme 1). Experimental studies have been unable to
resolve this issue, as evidence for both equal and unequal OH
Fig. 2 Comparison of calculated spectra (blue) of the lowest-energy
structures to the experimental spectra of the [Ho(acac)2L–2H]
+ ions
(black). Selected vibrational mode assignment for the two acetylacetonate
ligands (black) and the additional neutral ligands (red) are given.
Fig. 3 Correlation of the symmetric (blue) and antisymmetric (red) CO
stretch frequencies with the Ho–O (a) and C–O (b) bond lengths. The












+ ions. The blank line represents the C2v symmetry plane in
acetylacetonate. For the [Ho(acac–H)2(acac)]
+ complexes, one acac–H ligand
was bound symmetrically (left) and one asymmetrically (right)
Bond
Third ligand
— acac acac H2O MeOH
Ho–O 2.153 2.268 2.209 2.214 2.221
O–C 1.300 1.289 1.288 1.292 1.292
C–C 1.407 1.407 1.408 1.410 1.409
C–C 1.407 1.407 1.406 1.403 1.404
C–O 1.300 1.288 1.290 1.299 1.297
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bond lengths, resulting in C2v and Cs symmetry respectively,
has been reported.42,43
Coordination complex at m/z 423: [Ho(acac)2(CH3COOH)–2H]
+
In addition to the complexes discussed above, a Ho containing
ion at m/z 423 was observed, for which the experimental IR
spectrum is presented in black in Fig. 4. We hypothesize that
this mass peak corresponds to [Ho(acac–H)2]
+ with an addi-
tional acetic acid ligand. Acetic acid was also identified as one
of the degradation products of acac after neutron activation,9
but its presence here indicates that it is also a constituent of the
non-irradiated microspheres. In contrast to the complexes
discussed above, the acetylacetone and acetic acid ligands have
comparable acidities and it is not a priori clear which of them
deprotonate in the formation of the 1+ coordination complex.
Computed IR spectra for possible proto-isomers – in different
conformational configurations – are presented as the coloured
spectra in Fig. 4. The energetically most favourable complex
is predicted to possess two deprotonated acac ligands. The
neutral acetic acid coordinates to the holmium center in a
monodentate fashion and forms a hydrogen bond between its
OH group and the ketone oxygen atom of one of the [acac–H]
ligands (Fig. 4a). Two other conformations possess a free OH
group tilted away from the Ho center, adopting either a cis
(Fig. 4b, +17.8 kJ mol1) or trans (Fig. 4d, +26.3 kJ mol1)
configuration. For the proto-isomer featuring an acetate and a
neutral acac ligand, both the diketo (Fig. 4c) and enol (Fig. 4e)
form of the acac ligand were considered.
In the IR spectrum of the [Ho(acac)2(CH3COOH)  2H]+ ion,
three absorptions are observed above 1600 cm1, two distinct
bands at 1720 cm1 and 1660 cm1 and a small shoulder at
1630 cm1. This suggests the presence of at least three different
isomers, since all computed spectra show only one band in this
spectral range. The band at 1630 cm1 can be assigned as the
acetic acid CQO stretch of the lowest-energy structure (Fig. 4a).
The band at 1660 cm1 is identified as the CQO stretch of trans
acetic acid (Fig. 4d). The 30 cm1 redshift of this mode in the
lowest-energy structure is caused by a stronger coordination of
the acetic acid ligand, weakening the CO bond, as is reflected
in its 0.014 Å elongation. The hydrogen-bond gives partial
carboxylate character to the acetic acid ligand, making it a
stronger nucleophile, which results in a stronger coordination.
Concurrently, the hydrogen bond weakens the interaction
between [acac–H] and the metal center.
Finally, the CQO stretch band at 1720 cm1 is reproduced
well by the computed spectra of the complex that includes a cis
acetic acid ligand (Fig. 4b) and of the complex involving an
acetate anion and neutral acac in its diketo form (Fig. 4c). Of those
possibilities, only the acetate complex correctly reproduces the
weak band at 1155 cm1. For the two remaining complexes, the
cis acetic acid (Fig. 4b) and the enol tautomer of acac (Fig. 4e),
there is no direct spectroscopic evidence of their presence.
However, their computed spectra do not disagree severely with
the experimental IR spectrum, so that their contribution to the
ion population cannot be ruled out definitively.
Conclusions
In conclusion, five different Ho3+–acetylacetonate coordination
complexes, prepared from clinically relevant holmium-acetyl-
acetonate microspheres, have been characterized using IRIS. The
coordination geometries of these complexes have been estab-
lished on the basis of the good match between experimentally
observed and theoretically predicted vibrational bands. This
assignment resulted in a qualitative description of how the
binding properties of [acac–H] depend on the presence of a
third ligand, inducing a slightly asymmetric binding of the
[acac–H] ligands, reminiscent of the enol tautomer of neutral
acac. Moreover, infrared ion spectroscopy was able to identify
an unknown ligand binding to the holmium complex ion as
Fig. 4 Comparison of the calculated spectra (coloured) of selected
tautomers and conformers of the [Ho(acac)2(CH3COOH)–2H]
+ ion to
the experimental spectrum of the m/z 423 ion (black), with computed
relative free energies. The complexes with spectra in blue and orange
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acetic acid. The DFT calculations confirmed that the IR spectra
are minimally affected by the spin multiplicity of the metal center,
which reflects the marginal crystal field splitting in f-block metals.
Future studies will exploit IRIS to identify the byproducts formed
upon neutron activation of the microspheres.
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